Claims in the US medical malpractice (medmal) market are increasing, but underwriters are struggling to push through rate rises owing in part to high levels of latent capacity.
Claims in the US medical malpractice (medmal) market are increasing, but underwriters are struggling to push through rate rises owing in part to high levels of latent capacity.